Apyx Medical Corp (APYX)

$4.39 -0.01 (-0.23%)
Market Cap 153.73M
Revenue (ttm) 48.10M
Net Income (ttm) -23.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -48.77%
Debt to Equity Ratio 5.69
Volume 453,400
Avg Vol 115,060
Day's Range N/A - N/A
Shares Out 38.24M
Stochastic %K 85%
Beta 1.53
Analysts Strong Sell
Price Target $5.75

Company Profile

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use...

Industry: Medical Devices
Sector: Healthcare
Phone: 727 384 2323
Address:
5115 Ulmerton Road, Clearwater, United States
longshot2
longshot2 Feb. 2 at 7:14 PM
$APYX
0 · Reply
Growthataresonablecost
Growthataresonablecost Feb. 2 at 4:31 PM
$APYX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 26 at 10:34 AM
$APYX RSI: 65.36, MACD: 0.0760 Vol: 0.22, MA20: 3.69, MA50: 3.83 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockScanners
StockScanners Jan. 14 at 2:50 AM
$APYX reached 3.95
0 · Reply
StockScanners
StockScanners Jan. 13 at 4:55 AM
$$APYX keep watch if this holds above 3.80
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 12 at 1:35 PM
$APYX (+6.6% pre) Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results https://ooc.bz/l/89336
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 8:39 PM
$APYX RSI: 28.44, MACD: -0.0469 Vol: 0.21, MA20: 3.83, MA50: 3.64 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 20 at 12:43 AM
$APYX Share Price: $3.50 Contract Selected: Dec 18, 2026 $2.5 Calls Buy Zone: $1.49 – $1.84 Target Zone: $2.41 – $2.94 Potential Upside: 53% ROI Time to Expiration: 363 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
DARKP00L
DARKP00L Dec. 16 at 3:41 PM
$APYX 10:19 on Dec. 16 2025 Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 3:19 PM
Roth Capital updates rating for Apyx Medical ( $APYX ) to Buy, target set at 6.
0 · Reply
Latest News on APYX
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

Jan 12, 2026, 8:00 AM EST - 23 days ago

Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

Dec 3, 2025, 8:00 AM EST - 2 months ago

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

Nov 18, 2025, 7:30 AM EST - 2 months ago

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Nov 17, 2025, 4:05 PM EST - 2 months ago

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 2:36 PM EST - 3 months ago

Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Oct 23, 2025, 8:00 AM EDT - 3 months ago

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Apyx Medical Corporation - Special Call

Oct 14, 2025, 6:56 PM EDT - 4 months ago

Apyx Medical Corporation - Special Call

Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 1:52 PM EDT - 6 months ago

Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:01 PM EDT - 6 months ago

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 30, 2025, 4:20 PM EDT - 6 months ago

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

Renuvion® Brings Real Transformations to the Runway at Miami Swim Week

May 30, 2025, 9:00 AM EDT - 8 months ago

Renuvion® Brings Real Transformations to the Runway at Miami Swim Week

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

May 13, 2025, 8:00 AM EDT - 9 months ago

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript

May 11, 2025, 6:34 AM EDT - 9 months ago

Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript

Renuvion Introduces Television Star Dolores Catania as Chief of Confidence

May 1, 2025, 9:00 AM EDT - 9 months ago

Renuvion Introduces Television Star Dolores Catania as Chief of Confidence

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

Apr 29, 2025, 8:00 AM EDT - 10 months ago

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:45 AM EDT - 10 months ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Mar 25, 2025, 9:00 AM EDT - 11 months ago

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 11:48 AM EDT - 11 months ago

Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Jan 6, 2025, 8:00 AM EST - 1 year ago

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Nov 12, 2024, 4:05 PM EST - 1 year ago

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 1:39 PM EST - 1 year ago

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Nov 8, 2024, 7:05 AM EST - 1 year ago

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Nov 8, 2024, 7:00 AM EST - 1 year ago

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Aug 13, 2024, 8:10 AM EDT - 1 year ago

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 6:39 AM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jul 25, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

Jun 26, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript

May 11, 2024, 6:33 PM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

May 9, 2024, 7:05 AM EDT - 1 year ago

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

Apyx Medical Corporation Announces Board Leadership Transition

May 9, 2024, 7:00 AM EDT - 1 year ago

Apyx Medical Corporation Announces Board Leadership Transition

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apr 25, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Apr 11, 2024, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 10:12 AM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Mar 4, 2024, 7:30 AM EST - 2 years ago

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Feb 21, 2024, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Jan 22, 2024, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Jan 8, 2024, 7:00 AM EST - 2 years ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Nov 28, 2023, 8:30 AM EST - 2 years ago

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 11:30 AM EST - 2 years ago

Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Nov 9, 2023, 7:01 AM EST - 2 years ago

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

Nov 9, 2023, 7:00 AM EST - 2 years ago

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Nov 7, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Oct 2, 2023, 7:30 AM EDT - 2 years ago

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript

Aug 12, 2023, 12:09 PM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

Aug 10, 2023, 4:05 PM EDT - 2 years ago

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

Jun 29, 2023, 4:05 PM EDT - 2 years ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

longshot2
longshot2 Feb. 2 at 7:14 PM
$APYX
0 · Reply
Growthataresonablecost
Growthataresonablecost Feb. 2 at 4:31 PM
$APYX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 26 at 10:34 AM
$APYX RSI: 65.36, MACD: 0.0760 Vol: 0.22, MA20: 3.69, MA50: 3.83 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockScanners
StockScanners Jan. 14 at 2:50 AM
$APYX reached 3.95
0 · Reply
StockScanners
StockScanners Jan. 13 at 4:55 AM
$$APYX keep watch if this holds above 3.80
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 12 at 1:35 PM
$APYX (+6.6% pre) Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results https://ooc.bz/l/89336
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 8:39 PM
$APYX RSI: 28.44, MACD: -0.0469 Vol: 0.21, MA20: 3.83, MA50: 3.64 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 20 at 12:43 AM
$APYX Share Price: $3.50 Contract Selected: Dec 18, 2026 $2.5 Calls Buy Zone: $1.49 – $1.84 Target Zone: $2.41 – $2.94 Potential Upside: 53% ROI Time to Expiration: 363 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
DARKP00L
DARKP00L Dec. 16 at 3:41 PM
$APYX 10:19 on Dec. 16 2025 Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 3:19 PM
Roth Capital updates rating for Apyx Medical ( $APYX ) to Buy, target set at 6.
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 18 at 2:16 PM
$APYX (-13.6% pre) Apyx Medical prices $10 million stock offering at $3.62 per share https://ooc.bz/l/84958
0 · Reply
jarias115
jarias115 Nov. 17 at 9:15 PM
$APYX public offering… sorry guys
0 · Reply
StockScanners
StockScanners Nov. 13 at 3:26 AM
$APYX reached 4.44
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 2:13 PM
Citizens has updated their rating for Apyx Medical ( $APYX ) to Market Outperform with a price target of 8.
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 9 at 7:40 AM
$APYX Apyx Medical reports 12.1% revenue growth and 64.4% gross margin, fueled by AYON sales and record U.S. adoption. Check this out! https://biotechhealthx.com/biotech-news/apyx-medical-apyx-surges-15-after-record-q3-revenue-of-12-9m/
0 · Reply
cache1b
cache1b Nov. 9 at 12:05 AM
$APYX Pinging on scanner...
0 · Reply
cache1b
cache1b Nov. 8 at 11:50 PM
$APYX @LefDeppard in
3 · Reply
StockScanners
StockScanners Nov. 8 at 4:48 AM
$APYX keep watch if this holds above 3.50
0 · Reply
Stwts_scks
Stwts_scks Nov. 7 at 8:48 PM
$APYX Nice earnings... Next stop solid 4s then 5.
0 · Reply
Doozio
Doozio Oct. 14 at 7:04 PM
$APYX wen? It’s Tuesday.
0 · Reply
LukaMagic77
LukaMagic77 Oct. 14 at 5:02 PM
$APYX 🤩
0 · Reply
Doozio
Doozio Oct. 10 at 1:21 AM
$APYX the huckleberries shud meet their “potential” during 🐒🍌🧠⏰♾️
0 · Reply